RBC Capital Keeps Their Buy Rating on Select Medical (SEM)


In a report released today, Frank Morgan from RBC Capital reiterated a Buy rating on Select Medical (NYSE: SEM), with a price target of $24. The company’s shares opened today at $20.15.

According to TipRanks.com, Morgan is a 5-star analyst with an average return of 16.2% and a 67.6% success rate. Morgan covers the Services sector, focusing on stocks such as Encompass Health Corporation, Fresenius Medical Care Corp, and Envision Healthcare.

Currently, the analyst consensus on Select Medical is a Moderate Buy with an average price target of $24.

See today’s analyst top recommended stocks >>

The company has a one-year high of $21.65 and a one-year low of $15.85. Currently, Select Medical has an average volume of 533.2K.

Based on the recent corporate insider activity of 55 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Specialty Hospitals, Outpatient Rehabilitation and Concentra. The Specialty Hospitals segment involves in providing long term acute care hospital services and inpatient acute rehabilitative hospital care.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts